these data suggest that patients with type iia vwd synthesize an abnormal vwf protein that is susceptible to in vitro proteolytic degradation and that proteolytic degradation can play a significant role in the phenotypic expression of vwd by modifying the plasma and platelet vwf multimeric structure .
C1282968
type iia vwd
C0042974
vwd